HSP90AA1 and chronic kidney disease: Therefore, evidence from molecular dynamics simulations suggests that luteolin may act as a natural inhibitor of HSP90AA1, thereby preventing the maintenance of the conformation of proteins that play a key role in causing damage in CKD.